摘要 |
The invention provides the compounds of formula (I) in which: R<1> is selected from the group consisting of H, C1-6alkyl, C1-2alkyl substituted by one to five fluorine atoms, C3-6alkenyl, C3-10cycloalkylC0-6alkyl, C4-12bridged cycloalkyl, A(CR<4>R<5>)n and b(CR<4>R<5>)n; R<2> is C1-2alkyl substituted by one to five fluorine atoms; R<3> is selected from the group consisting of C1-6alkyl, NH2 and R<7>CONH; R<4> and R<5> are independently selected from H or C1-6alkyl; A is an unsubstituted 5- or 6-membered heteroaryl or an unsubstituted 6-membered aryl, or a 5- or 6-membered heteroaryl or a 6-membered aryl substituted by one or more R<6>; R<6> is selected from the group consisting of halogen, C1-6alkyl, C1-6alkyl substituted by one or more fluorine atoms, C1-6alkoxy, C1-6alkoxy substituted by one or more F, NH2SO2 and C1-6alkylSO2; B is selected from the group consisting of Formula (i) and (ii) and where (iv) defines the point of attachment of the ring; R<7> is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO2CC1-6alkyl, C1-6alkylOCOC1-6alkyl, C1-6alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl; and n is 0 to 4. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in treatment of the pain, fever and inflammation of variety of conditions and diseases.
|
申请人 |
GLAXO GROUP LIMITED;NAYLOR, ALAN;PAYNE, JEREMY, JOHN;PEGG, NEIL, ANTHONY |
发明人 |
NAYLOR, ALAN;PAYNE, JEREMY, JOHN;PEGG, NEIL, ANTHONY |